Invention Application
![SUBSTITUTED 3-AZABICYCLO[3.1.0]HEXANES AS KETOHEXOKINASE INHIBITORS](/docs/US/2020-05-14/US20200148669A1/abs.jpg.600x600.jpg)
- Patent Title: SUBSTITUTED 3-AZABICYCLO[3.1.0]HEXANES AS KETOHEXOKINASE INHIBITORS
-
Application No.: US16744283Application Date: 2020-01-16
-
Publication No.: US20200148669A1Publication Date: 2020-05-14
- Inventor: Matthew Dowling , Dilinie Fernando , Kentaro Futatsugi , Kim Huard , Thomas Victor Magee , Brian Raymer , Andre Shavnya , Aaron Smith , Benjamin Thuma , Andy Tsai , Meihua Tu
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Main IPC: C07D403/14
- IPC: C07D403/14 ; C07D403/04 ; C07D401/14 ; C07D401/04 ; A61K31/403
![SUBSTITUTED 3-AZABICYCLO[3.1.0]HEXANES AS KETOHEXOKINASE INHIBITORS](/abs-image/US/2020/05/14/US20200148669A1/abs.jpg.150x150.jpg)
Abstract:
Provided herein are substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors, processes to make said compounds, and methods comprising administering said compounds to a mammal in need thereof.
Public/Granted literature
- US10787438B2 Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors Public/Granted day:2020-09-29
Information query
